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Abstract
Background: Down syndrome (DS) is the most common and best-known chromosomal disorder
and is associated with several other pathologic conditions including immunodeficiency which makes
a significant contribution to morbidity and mortality. Various immunological theories and
observations to explain the predisposition of individuals with DS to various infections have been
published, one of which is increased apoptotic cells.
Aim: The aim of this study was to identify the effect of apoptosis on both types of cells of specific
immune response (T and B lymphocytes) in children with DS using Annexin V staining of
phosphatidyserine (PS) as a specific marker of early apoptosis.
Subjects and methods: The study included 17 children with karyotypically ascertained DS (7
males and 10 females). Their ages ranged from 4 months to 14 years with mean age of 5.7 ± 4.35
years. Seventeen age and sex matched healthy children were included in the study as controls.
Patients or controls with infections were excluded from the study. Complete blood picture,
immunophenotyping, analysis of apoptosis using Annexin V was done at National cancer Institute
to all children included in this study.
Results: Although CBC, differential count, relative and absolute number of CD3+ and CD16+ did
not show significant differences between DS children and control group, the relative and the
absolute size of apoptotic CD3+ T lymphocytes, and the relative size of apoptotic CD19+ B
lymphocytes were significantly higher in DS children than in controls. On the other hand, no
significant difference was detected as regards the absolute size of CD19+ B lymphocytes in DS
children and in controls
Conclusion: our finding of increased early apoptotic cells (especially T cells) in DS children may
emphasize the fact that the function of cells- and not their number- is main mechanism responsible
for the impairment of the immune system in DS children and may further add to the known fact
that cellular immunity is more severely affected than humoral immunity in these children. Further
studies on apoptotic cellular phenotype in larger number of DS are needed
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Introduction
Down syndrome (DS) is the most common and best-
known chromosomal disorder. It is associated with sev-
eral pathologic conditions including immunodeficiency
which makes a significant contribution to morbidity and
mortality in these children. Various immunological theo-
ries and observations to explain the predisposition of
individuals with DS to infections have been published [1-
6]. One of the most interesting; is the "precocious aging"
theory in which increased apoptosis is the main corner-
stone [7]. Previous authors reported increased apoptotic
cells in neurons and granulocytes of DS patients [8,9]. It
has also been studied in the peripheral blood by means of
electron microcopy, in situ nick translation (ISNT) and
DNA electrophoresis [10]. These methods detects only
late events of apoptosis (apoptotic body formation and
fragmentation of DNA into oligonucleosomal fragments).
Early apoptosis can be detected using Annexin V staining
of phosphatidyserine (PS). This method has been used
before by Corsi et al., 2003 who reported an increase in
early apoptotic CD3 lymphocytes in DS children com-
pared to the controls [11]. However, the effect of apopto-
sis on both types of cells of specific immune response (T
and B lymphocytes) was not studied before.
The aim of this study was to identify the effect of apopto-
sis on both types of cells of specific immune response (T
and B lymphocytes) in children with DS using Annexin V




The study included 17 children with karyotypically ascer-
tained DS (7 males and 10 females) from the genetics
clinic, Ain Shams University. Their ages ranged from 4
months to 14 years with mean age of 5.7 years ± 4.3 years
and a median of 7 years. Seventeen age and sex matched
healthy children were included in the study as controls.
Each patient had a karyotypically normal control from the
same age and sex (controls were actually healthy patients'
sibs to stabilize diet and other environmental factors that
may affect immunity). Patients or controls with respira-
tory, urinary tract, gastrointestinal or other infections were
excluded from the study. Complete blood picture and
analysis of apoptosis were done in the National cancer
Institute to all children included in this study.
Methods
1-Complete blood count and immunophenotyping
The relative and the absolute leukocyte counts were deter-
mined with a Sysmex SE-9500 hematology analyzer (Sys-
mex, Kobe, Japan). The region of lymphocyte population
(lymphocyte gate), was set manually, based on the for-
ward-scatter and side-scatter characteristics (Beckman
Coulter flow cytometer, USA). The relative count of each
lymphocyte subpopulation was expressed as a percentage
within the total lymphocyte population. The absolute
count of each lymphocyte subpopulation (CD3+  and
CD19+  lymphocytes) was calculated from the relative
count of the lymphocyte subpopulation, the relative
count of the total lymphocyte population, and the abso-
lute leukocyte count [12].
2-Apoptosis in peripheral T- and B-lymphocytes
During apoptosis, externalization of phosphatidyserine
(PS) and phosphatidylethanolamine is a hallmark of the
changes in the cell surface. These phospholipids are nor-
mally sequestered within the cell surface on the cytoplas-
mic side of the plasma membrane. This occurs relatively
early just after segmentation of the nucleus during which
the cell membrane remains intact [13].
The permeability of the plasma membrane is a central dif-
ference between necrosis and apoptosis. Large molecular
DNA binding dyes, such as propidium iodide (PI), can
not enter intact cells because of their large size and with-
out permebilization treatment, and do not label apoptotic
cells until the final lysis stage. Annexin V, a Ca2-dependent
phospholipids binding protein, which possesses high
affinity for PS can be used specifically for detecting early
apoptotic cells. When used with promidium iodide (PI),
Annexin V staining allows the quantification of cells at
early stages of apoptosis and the simultaneous identifica-
tion of cell surface markers [14].
In this study, apoptosis in T- and B-lymphocytes was
measured by staining with Fluorescein isothiocyanate
(FITC) conjugated annexin V, and Propidium iodide (PI)
using IQ products Phosphatidyl Serine Detection Kit
(IQP-116F). Indotricarbocyanine (Cy5) coupled to Phy-
coerythrin (PE) conjugated anti-CD3 (PE-Cy5) IQP-519
and anti-CD19 (PE-Cy5) Dako-C7066 antibodies were
used to identify apoptotic cell phenotype. Three-color
flow cytometry analysis was performed on a BCKMAN
Coulter equipped with a single 488 nm argon ion laser. At
least 10,000 events were acquired for each sample. The
voltages and compensation were set according to the
standard procedure, using negative controls and tested
cells stained in a single color or a combination of colors.
The proportion of FITC+/PI-, corresponding to early
apoptosis in T and B lymphocytes, was evaluated by gat-
ing for CD3-PE-Cy5 and CD19-PE-Cy5.
Results
1-Complete blood picture (CBC) and differential count
Red blood cells, count, haemoglobin level, heamatocrite
level, mean corpuscular volume, mean corpuscular hea-
moglobin, platelets and total leucocytic counts did not
show significant difference between DS children and con-Immunity & Ageing 2009, 6:2 http://www.immunityageing.com/content/6/1/2
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trol group. No significant difference was also observed
between the percentage and the absolute values of neu-
trophils, lymphocytes, monocytes or eosinophils between
DS and normal children. The percentage of basophils was
significantly higher in DS children but no significant dif-
ference was detected when absolute values were com-
pared.
2-Lymphocyte population
Neither the absolute nor the relative values for CD3+ T
lymphocytes and CD19+ B lymphocytes showed a signifi-
cant difference between children with DS and controls. A
slight lower figure was noted in absolute value of CD19+ B
lymphocytes in DS children (table 1).
3-Early apoptosis in peripheral blood T and B lymphocytes
• CD3+ T lymphocytes: Both relative and the absolute size
of early apoptotic CD3+ T lymphocytes, were significantly
higher in DS children than in controls.
￿ CD19+ B lymphocytes: The relative size of early apoptotic
CD19+ B lymphocytes were significantly higher in DS chil-
dren than in controls, however, the absolute size was
insignificantly higher in DS children compared to the con-
trols, (table 2) and (figure 1, figure 2)
Discussion
An impairment of both specific and non-specific immu-
nity has been documented in patients with DS. Decreased
neutrophil chemotaxis, leucocytes opsonization, and
phagocytosis and leucocytes bactericidal activity were
described in children with DS [15].
Several studies have focused their attention on the role of
the thymus, and have described a variety of structural and
anatomic alterations present in DS [16]. Studies of T-cell
phenotype and function have frequently resulted in con-
flicting results, the overall evidence strongly pointed to a
primary and profound impairment of T-cell mediated
immunity [17].
In this work, neither the absolute nor the relative values
for CD3+ T lymphocytes and CD19+ B lymphocytes showed
a significant difference between children with DS and
controls. Previous quantitative studies of peripheral
blood T lymphocytes revealed a reduction, often quite
small, in the percentage and/or absolute number of T lym-
phocytes, although normal proportions or numbers of T
and B lymphocytes in DS children have also been reported
[1,11].
Apoptosis, or programmed cell death, is a well-docu-
mented phenomenon in many cellular systems. It plays a
key role in tissue and organ development during embryo-
genesis as well as in adult tissues during cell turn-over. It
was suggested that apoptosis provides the mechanism for
deletion of auto reactive T-cells in the thymus, low
responsive B-cells in the germinal center, and of target
cells attacked by cytotoxic T-lymphocytes and natural
killer cells [13].
Previous studies evaluated apoptosis in peripheral blood
of patients with DS by different methods but did not iden-
tify the phenotype of apoptotic cells [10]. In our work,
both relative and absolute number of early apoptotic T
cells (CD3+ annexinV positive cells), were significantly
lower in DS children while the absolute number of T-lym-
phocytes was insignificantly different. In other words, the
function and not the number of T lymphocytes is the
main mechanism responsible for the impairment of
immunity in these children. This result supports the find-
ing of Corsi et al., 2003 who explained this increase in
apoptotic T cells by antigen overload combined with
impairment of nutrient absorption (like zinc) secondary
to altered function of the gastrointestinal mucosa [11].
Actually, decrease in number of apoptotic cells was
observed after zinc supplementation in these children
[10].
In our study, although both T and B cells showed
increased apoptosis, B cells were less functionally
impaired (as their absolute number was insignificantly
different), which agrees with previous studies reporting






CD3+ T lymphocytes Percentage 67.19 ± 11.81 62.11 ± 10.31 0.163
Absolute (×103/μl) 2.44 ± 3.05 2.16 ± 1.17 0.687
CD19+ B lymphocytes Percentage 13.20 ± 5.74 17.39 ± 7.27 0.136
Absolute (×103/μl) 0.40 ± 0.31 0.67 ± 0.61 0.076Immunity & Ageing 2009, 6:2 http://www.immunityageing.com/content/6/1/2
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that humoral immunity is less-strikingly impaired in these
children [17] and necessitates further study on a larger
scale of DS population to confirm this finding.
On the other hand, Roat et al., 2007 found that DS
peripheral blood mononuclear cells (PBMNC) with
altered mitochondrial function do not undergo apoptosis,
and hypothesized that DS patients tend to maintain dam-
aged cells, or that they have a higher capacity to repair
functional damages. They added that it remains to be
established if and how this phenomenon can be linked to
the development of autoimmunity or neoplastic disor-
ders. In contrast to their study, we studied only lym-
phocytes and not all PBMNC and that may explain the
difference between the two studies [18].
Other authors implicate the absence of early expansion of
T and B-lymphocytes in the peripheral blood of children
with DS in the first year of life as the main cause of recur-
rent infections in early life of these children. They found
also that T-lymphocyte subpopulation gradually
approaches those of normal children over time which
contradicts the theory of precocious aging. Nevertheless it
does not explain the observed disturbance in the adaptive
immune system in DS after the first year [12].
In conclusion, our finding of increased early apoptotic
cells (especially T cells) in DS children may emphasize the
fact that the function of cells- and not their number- is
main mechanism responsible for the impairment of the
immune system in DS children and may further add to the
known fact that cellular immunity is more severely
affected than humorral immunity in these children. Fur-
Flow cytometric analysis of apoptotic CD3+ T-lymphocytes in a healthy control Figure 1
Flow cytometric analysis of apoptotic CD3+ T-lymphocytes in a healthy control. From left to right: 1-dot plot show-
ing gating on total lymphocytes, 2-dot plot showing gating on CD3+ T-lymphocytes, 3-dot plot showing the proportion of early 
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Flow cytometric analysis of apoptotic CD3+ positive T-lym- phocytes in a child with Down syndrome Figure 2
Flow cytometric analysis of apoptotic CD3+ positive 
T-lymphocytes in a child with Down syndrome. The 
percentage of FITC+/PI-in the upper left quadrant (early 
apoptotic cells), and the FITC+/PI+ in the upper right quad-
rant (late apoptotic cells) as well as the FITC-/PI+ (necrotic) 
cells in the lower right quadrant after gating on CD3+ cells in 
a DS child.
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ther studies on apoptotic cellular phenotype in larger
number of DS are needed.
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CD3 Percentage 32.11 ± 13.57 9.65 ± 8.04 0.001
Absolute (×10>3/μl) 0.79 ± 1.19 0.18 ± 0.13 0.001
CD19 Percentage 27.85 ± 16.68 13.54 ± 12.36 0.022
Absolute (×103/μl) 0.10 ± 0.07 0.08 ± 0.11 0.286